The PTEN/MMAC1 Tumor Suppressor Phosphatase Functions As a Negative Regulator of the Phosphoinositide 3-kinase/Akt Pathway

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 Dec 23

PMID 9861013

Citations 194

Authors

X Wu

K Senechal

M S Neshat

Y E Whang

C L Sawyers

Affiliations

Soon will be listed here.

Abstract

The PTEN/MMAC1 phosphatase is a tumor suppressor gene implicated in a wide range of human cancers. Here we provide biochemical and functional evidence that PTEN/MMAC1 acts a negative regulator of the phosphoinositide 3-kinase (PI3-kinase)/Akt pathway. PTEN/MMAC1 impairs activation of endogenous Akt in cells and inhibits phosphorylation of 4E-BP1, a downstream target of the PI3-kinase/Akt pathway involved in protein translation, whereas a catalytically inactive, dominant negative PTEN/MMAC1 mutant enhances 4E-BP1 phosphorylation. In addition, PTEN/MMAC1 represses gene expression in a manner that is rescued by Akt but not PI3-kinase. Finally, higher levels of Akt activation are observed in human prostate cancer cell lines and xenografts lacking PTEN/MMAC1 expression when compared with PTEN/MMAC1-positive prostate tumors or normal prostate tissue. Because constitutive activation of either PI3-kinase or Akt is known to induce cellular transformation, an increase in the activation of this pathway caused by mutations in PTEN/MMAC1 provides a potential mechanism for its tumor suppressor function.

Citing Articles

Evaluation of Methylation and Changes in the Transcriptomics and Proteomics of the GRHL3, PHLDA3, and in Patients with Head and Neck Squamous Cell Carcinoma.

Shakoori A, Azarian M, Hosseinpour Aghaei M, Maddahi M, Aghazadeh K, Tabari A Indian J Otolaryngol Head Neck Surg. 2025; 77(1):13-21.

PMID: 40070988 PMC: 11890821. DOI: 10.1007/s12070-024-05057-0.

The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia.

Marton A, Veres K, Erdodi F, Udvardy M, Illes A, Rejto L Pathol Oncol Res. 2024; 30:1611747.

PMID: 39035053 PMC: 11257863. DOI: 10.3389/pore.2024.1611747.

TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis.

Hao X, Lv Y, Li D, Bai F, Gong J, Pan G J Transl Med. 2024; 22(1):6.

PMID: 38167440 PMC: 10763294. DOI: 10.1186/s12967-023-04721-3.

PTEN is both an activator and a substrate of chaperone-mediated autophagy.

Zhang K, Burns C, Skinner M, Lombard D, Miller R, Endicott S J Cell Biol. 2023; 222(9).

PMID: 37418003 PMC: 10327811. DOI: 10.1083/jcb.202208150.

PARK7 deficiency inhibits fatty acid β-oxidation via PTEN to delay liver regeneration after hepatectomy.

Qu X, Wen Y, Jiao J, Zhao J, Sun X, Wang F Clin Transl Med. 2022; 12(9):e1061.

PMID: 36149763 PMC: 9505755. DOI: 10.1002/ctm2.1061.

References

Horoszewicz J, Leong S, Kawinski E, Karr J, Rosenthal H, Chu T . LNCaP model of human prostatic carcinoma. Cancer Res. 1983; 43(4):1809-18. View

Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi P . Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998; 19(4):348-55. DOI: 10.1038/1235. View

Senechal K, Heaney C, Druker B, Sawyers C . Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells. Mol Cell Biol. 1998; 18(9):5082-90. PMC: 109093. DOI: 10.1128/MCB.18.9.5082. View

Paradis S, Ruvkun G . Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 1998; 12(16):2488-98. PMC: 317081. DOI: 10.1101/gad.12.16.2488. View

Matthews R, Bowne D, Flores E, Thomas M . Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol. 1992; 12(5):2396-405. PMC: 364412. DOI: 10.1128/mcb.12.5.2396-2405.1992. View

Muller A, Pendergast A, Havlik M, Puil L, Pawson T, Witte O . A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction. Mol Cell Biol. 1992; 12(11):5087-93. PMC: 360442. DOI: 10.1128/mcb.12.11.5087-5093.1992. View

Marshall C . Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995; 80(2):179-85. DOI: 10.1016/0092-8674(95)90401-8. View

Sun H, Tonks N . The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends Biochem Sci. 1994; 19(11):480-5. DOI: 10.1016/0968-0004(94)90134-1. View

Klingmuller U, Lorenz U, Cantley L, Neel B, Lodish H . Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 1995; 80(5):729-38. DOI: 10.1016/0092-8674(95)90351-8. View

10.

Datta K, Franke T, Chan T, Makris A, Yang S, Kaplan D . AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Mol Cell Biol. 1995; 15(4):2304-10. PMC: 230458. DOI: 10.1128/MCB.15.4.2304. View

11.

Franke T, Yang S, Chan T, Datta K, Kazlauskas A, Morrison D . The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995; 81(5):727-36. DOI: 10.1016/0092-8674(95)90534-0. View

12.

Raitano A, Halpern J, Hambuch T, Sawyers C . The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci U S A. 1995; 92(25):11746-50. PMC: 40479. DOI: 10.1073/pnas.92.25.11746. View

13.

Songyang Z, Cantley L . Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem Sci. 1995; 20(11):470-5. DOI: 10.1016/s0968-0004(00)89103-3. View

14.

Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M . Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum Gene Ther. 1995; 6(11):1417-26. DOI: 10.1089/hum.1995.6.11-1417. View

15.

Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N . Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci U S A. 1996; 93(3):1065-70. PMC: 40031. DOI: 10.1073/pnas.93.3.1065. View

16.

Tonks N . Protein tyrosine phosphatases and the control of cellular signaling responses. Adv Pharmacol. 1996; 36:91-119. DOI: 10.1016/s1054-3589(08)60578-5. View

17.

Tonks N, Neel B . From form to function: signaling by protein tyrosine phosphatases. Cell. 1996; 87(3):365-8. DOI: 10.1016/s0092-8674(00)81357-4. View

18.

Vanhaesebroeck B, Stein R, Waterfield M . The study of phosphoinositide 3-kinase function. Cancer Surv. 1996; 27:249-70. View

19.

Datta K, Bellacosa A, Chan T, Tsichlis P . Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J Biol Chem. 1996; 271(48):30835-9. DOI: 10.1074/jbc.271.48.30835. View

20.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View